Mjali A, Obaid M, Matti B, Abbas N. Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. apjcc [Internet]. 14Jun.2022 [cited 16Apr.2024];7(2):267-72. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/870